Share of Oncology treatment hospital is in focus after it jumps more than 20 percent in last five days from Rs 498 per share to 593.45 per share, reason for sudden rise in Hospital share is because of capacity expansion and more than 60 percent of bed consumption which makes the cost of per bed to Hospital down, Company have over 22 cancer care center in India.

Comapny Overview:

HEALTHCARE GLOBAL ENTERPRISES LTD.(HCG) is a leading chain of cancer treatment hospital with a market capitalization of Rs. 8273 crore, with 52 week low of Rs. 330.65 and 52 week high of Rs. 598 and now company is trading at its all time high it's because of company operates in Cancer treatment which is a critical department and low compitetion segment of Healthcare

Company postioned it self a top player in oncology treatment sector with persence over 18 states in India and it is also catering to the International patients, overall company is in a very good position to grow from here because of per bed cost is getting low and unfortunetly increase in cancer cases. 

Financial overview of the Company:

With MarketCap of Rs.8273 crore and price to earning(P/E) of 149.17, Three year CAGR of revenue is 15.69 percent, now if talk about revenue and net profit YOY basis revenye increased 20 percent from Rs.1691 crore in FY23 to Rs.1908 in FY24 which is only three quater numbers of FY24, Q4 numbers are yet to be declare.

About The Company:

HCG – the Specialist in Cancer Care is one of the largest chains of cancer hospitals in India. The network comprises 22 comprehensive cancer centres spanning 18 cities. Hospitals function with a hub and spoke model, where they have super-specialized cancer hospitals with high-end diagnostic and treatment facilities referred to as “hubs,” and then there are comprehensive cancer hospitals, referred to as “spokes,” which are supported by our super-specialty hospitals.

This model helps them make the highest-quality cancer care accessible to cancer patients coming from different walks of life, allowing them to receive the care they deserve.

Disclamier:

This article is purely for knowledge purpose before any investment ask your financial advisor